The CorDx HCG PREGNANCY TEST MIDSTREAM KIT FOR SELF TESTING is a rapid test for the qualitative detection of human chorionic gonadotropin (hCG) in urine species to aid in the early detection of pregnancy. It is intended for home users and for prescription use.
Featuresï¼?
accuracy>99.5%
sensitivity: 25miu /ml
rapid: result is readable as quick as in 1 minute.
specimen: urine, widely used for self-testing.
shelf life: 36months or 24months
packing:1pc/box, 3pcs/box
CE and FDA approved
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
EUA and CE pass
shelf life: 24months since manufacturing date
packing:2pcs/box,4pcs/box and so on
It is for self testing and OTC, for home use, school , and any group .
The CorDx COVID-19 Ag Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus.
View File Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 7 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests.
